{
    "title": "Pharmaceutical sector sees flurry of mergers and takeovers: Which deals will work and which might self-destruct?",
    "url": "https://www.dailymail.co.uk/money/markets/article-2612588/CITY-FOCUS-Deals-mix-pharmaceutical-giants.html",
    "date": "2014-04-24",
    "keywords": [
        "shareholder",
        "value",
        "pfizer",
        "growth",
        "sector",
        "view",
        "boss",
        "bid",
        "healthcare",
        "pharma",
        "cent",
        "drug",
        "soriot",
        "deal",
        "firm",
        "flurry",
        "cancer",
        "merger",
        "yesterday",
        "executive",
        "astrazeneca",
        "city",
        "approach",
        "business",
        "way",
        "bestselling",
        "patent",
        "protection",
        "analyst",
        "mail",
        "gmt",
        "april",
        "email",
        "industry",
        "astrazenecas",
        "yesterdaya",
        "botox",
        "wrinkle",
        "treatmentmaker",
        "allergan",
        "investor",
        "bill",
        "ackman",
        "partner",
        "home",
        "drugmaker",
        "glaxosmithkline",
        "approval",
        "asset",
        "swap",
        "consumer",
        "joint",
        "venturegsk",
        "glaxowellcome",
        "smithkline",
        "beecham",
        "az",
        "group",
        "virgin",
        "course",
        "return",
        "product",
        "breakup",
        "purchase",
        "transaction",
        "point",
        "wave",
        "bolton",
        "blow",
        "astraastrazeneca",
        "revolt",
        "pay",
        "david",
        "brennan",
        "springanalysis",
        "voting",
        "meeting",
        "ftse",
        "report",
        "remuneration",
        "poll",
        "setback",
        "rise",
        "firstquarter",
        "exchange",
        "consensus",
        "sir",
        "advocate",
        "novartis",
        "tuesday",
        "witty",
        "problem",
        "past",
        "antiinfection",
        "neuroscience",
        "priority",
        "respiratory",
        "inflammationthe",
        "stance",
        "fact"
    ],
    "category": [
        "money",
        "markets"
    ]
}